Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | Director | May 07, 2026 | May 11, 2026 |
| Privia Health Group, Inc.PRVA · Entity 1532 | Director | May 21, 2025 | May 23, 2025 |
| TENNANT COTNC · Entity 4843 | Director | December 03, 2020 | December 07, 2020 |
| UNITEDHEALTH GROUP INCUNH · Entity 2809 | Director · Chief Executive Officer | December 15, 2020 | December 17, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,382 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 3,800 · Balance 45,382 F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.
Privia Health Group, Inc.
Report date May 21, 2025 · Filed May 23, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 25,709 |
Reported balance
After 2025-05-21 transaction · row 1
1 source rowRow 1 · 2025-05-21 · Grant · Acquired 8,396 · Balance 25,709 F1: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectSee Footnote | 1,315,340 |
Reported balance
Holding disclosure · report date 2025-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,315,340 F2: Represents shares held by Jory Capital, LLC, which is co-owned by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
F2: Represents shares held by Jory Capital, LLC, which is co-owned by the Reporting Person.
TENNANT CO
Report date December 03, 2020 · Filed December 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,722 |
Ending reported balance
After 2020-12-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-12-03 · Exercise / conversion · Acquired 1,750 · Balance 16,472 Row 2 · 2020-12-03 · Sale · Disposed 1,750 · Balance 14,722 F1: Reflects the weighted average price of 1,750 shares of common stock of Tennant Company sold by the reporting person in multiple transactions on December 3, 2020 with sale prices ranging from $67.6321 to $67.6323 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.81 · Expires 2021-04-28 | Direct | 0 |
Reported balance
After 2020-12-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-12-03 · Exercise / conversion · Disposed 1,750 · Balance 0 F2: Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the weighted average price of 1,750 shares of common stock of Tennant Company sold by the reporting person in multiple transactions on December 3, 2020 with sale prices ranging from $67.6321 to $67.6323 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Fully vested.
UNITEDHEALTH GROUP INC
Report date December 15, 2020 · Filed December 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 967,872.399 |
Ending reported balance
After 2020-12-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-12-15 · Grant · Acquired 113.465 · Balance 968,337.735 F1: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Row 2 · 2020-12-16 · Tax withholding · Disposed 465.336 · Balance 967,872.399 F2: Represents the cancellation of shares for the payment of a FICA tax liability. |
| Common StockSEC Table I · non-derivative | Indirectby 401(k) | 242.5838 |
Reported balance
Holding disclosure · report date 2020-12-15 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 242.5838 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
F2: Represents the cancellation of shares for the payment of a FICA tax liability.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2026 Filed May 11, 2026 20:33 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-005114 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,382 F1 · kind: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:03 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, par value $0.01 per share | 8,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-25-000075 · wk-form4_1748034223.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,709 F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 08, 2025 Filed May 9, 2025 21:35 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 2,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004935 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,582 F1 · kind: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:02 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, par value $0.01 per share | 11,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-24-000087 · wk-form4_1716498166.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,313 F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:37 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 2,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005972 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,501 F1 · kind: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:31 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, par value $0.01 per share | 6,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001268489-23-000010 · wk-form4_1691094703.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,189 F2 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the day immediately preceding the date of Company's 2024 Annual Meeting of Stockholders. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:27 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 3,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005471 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,600 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $205,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 23:21 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004618 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,654 F1 · shares: Restricted stock granted in lieu of 100% of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $2,083.33, divided by the closing price of common stock on the date of grant. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:08 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 2,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006634 · doc4.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,613 F2 · shares: Restricted stock granted in lieu of 100% of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $115,000, divided by the closing price of common stock on the date of grant. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:08 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 4,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006634 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,877 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $205,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 21:20 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | PurchaseCommon Stock | 25,000 | $41.98 | $1,049,450.00 |
DisclosureSEC source: 0001225208-21-013899 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · price: Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $41.79 to, $42.09, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:12 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantDeferred Stock Units · Derivative | 2,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-010280 · doc4.xml · derivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,389 Underlying: Common Stock · 2,296 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · shares: Reflects a value of approximately $99,600 (representing the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant. F5 · derivative.exercise_date: Grant of deferred stock units in lieu of yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan. F5 · derivative.expiration_date: Grant of deferred stock units in lieu of yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:12 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantDeferred Stock Units · Derivative | 4,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-010280 · doc4.xml · derivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,093 Underlying: Common Stock · 4,093 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · shares: Reflects a value of approximately $177,500 (representing the prorated amount of the non-employee director compensation program's annual equity grant having a value of $205,000) divided by the closing price of common stock on the date of grant. F3 · derivative.exercise_date: Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan. F3 · derivative.expiration_date: Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 22:19 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 465.336 | $339.34 | $157,907.12 |
DisclosureSEC source: 0001209191-20-064149 · doc4.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967,872.399 F2 · shares: Represents the cancellation of shares for the payment of a FICA tax liability. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:19 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 113.465 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-064149 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,337.735 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:11 UTC | TENNANT CO TNC · Entity 4843 | Exercise / conversionStock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $40.81 | $0.00 |
DisclosureSEC source: 0001179110-20-011725 · edgar.xml · derivative · entry 3 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires 2021-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:11 UTC | TENNANT CO TNC · Entity 4843 | SaleCommon Stock | 1,750 | $67.63 | $118,356.35 |
DisclosureSEC source: 0001179110-20-011725 · edgar.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,722 F1 · price: Reflects the weighted average price of 1,750 shares of common stock of Tennant Company sold by the reporting person in multiple transactions on December 3, 2020 with sale prices ranging from $67.6321 to $67.6323 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:11 UTC | TENNANT CO TNC · Entity 4843 | Exercise / conversionCommon Stock | 1,750 | $40.81 | $71,417.50 |
DisclosureSEC source: 0001179110-20-011725 · edgar.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 21:24 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 130.419 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-051936 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,224.27 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:19 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 597 | $323.70 | $193,248.90 |
DisclosureSEC source: 0001209191-20-046943 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,093.851 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:00 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 134.941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040480 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,606.883 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| May 11, 2020 Filed May 13, 2020 23:25 UTC | TENNANT CO TNC · Entity 4843 | GrantCommon Stock | 1,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-005928 · edgar.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,722 F1 · shares: Non-Employee Director restricted stock unit grant. Read SEC document |
| March 24, 2020 Filed Mar 26, 2020 20:39 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 155.686 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-021275 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,471.942 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 22:48 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 1,199 | $263.00 | $315,337.00 |
DisclosureSEC source: 0001209191-20-014098 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,316.256 Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 60,791 | $0.00 Strike: $302.20 | $0.00 |
DisclosureSEC source: 0001209191-20-010124 · doc4.xml · derivative · entry 8 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,791 Underlying: Common Stock · 60,791 shares Expires 2030-02-13 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 13 from the years 2021 through 2024. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 10,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010124 · doc4.xml · nonDerivative · entry 6 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969,515.256 F3 · shares: The restricted stock units will vest at a rate of 25% annually on February 13 from the years 2021 through 2024. F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 13, 2020, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Awards is 21,179. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 7,422 | $302.20 | $2,242,928.40 |
DisclosureSEC source: 0001209191-20-010124 · doc4.xml · nonDerivative · entry 5 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 958,925.256 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2017-2019. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 15,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010124 · doc4.xml · nonDerivative · entry 4 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,347.256 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2017-2019. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 17,400 | $302.20 | $5,258,280.00 |
DisclosureSEC source: 0001209191-20-010124 · doc4.xml · nonDerivative · entry 3 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 951,263.256 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2017-2019. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 35,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010124 · doc4.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968,663.256 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2017-2019. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 1,478 | $302.20 | $446,651.60 |
DisclosureSEC source: 0001209191-20-010124 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,298.256 Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:58 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionStock Appreciation Rights · Derivative | 76,024 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001209191-20-008355 · doc4.xml · derivative · entry 6 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,024 shares Expires 2020-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested at a rate of 25% on February 9 from the years 2011 through 2014. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:58 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 41,761 | $289.22 | $12,078,116.42 |
DisclosureSEC source: 0001209191-20-008355 · doc4.xml · nonDerivative · entry 4 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 934,776.256 Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:58 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 76,024 | $33.00 | $2,508,792.00 |
DisclosureSEC source: 0001209191-20-008355 · doc4.xml · nonDerivative · entry 3 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,537.256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:58 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 1,398 | $289.22 | $404,329.56 |
DisclosureSEC source: 0001209191-20-008355 · doc4.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,513.256 Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:58 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 1,850 | $289.22 | $535,057.00 |
DisclosureSEC source: 0001209191-20-008355 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 901,911.256 Read SEC document |
| December 18, 2019 Filed Dec 19, 2019 22:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 534.346 | $292.90 | $156,509.94 |
DisclosureSEC source: 0001209191-19-061365 · doc4.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 903,758.256 F2 · shares: Represents the cancellation of shares for the payment of a FICA tax liability. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 22:26 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 123.954 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061365 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904,292.602 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 22:01 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 163.11 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-050903 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904,168.648 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 20:36 UTC | TENNANT CO TNC · Entity 4843 | Exercise / conversionStock Option (right to buy) · Derivative | 2,256 | $0.00 Strike: $34.28 | $0.00 |
DisclosureSEC source: 0001179110-19-009712 · edgar.xml · derivative · entry 5 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,256 shares Expires 2020-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 20:36 UTC | TENNANT CO TNC · Entity 4843 | Exercise / conversionStock Option (right to buy) · Derivative | 1,385 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001179110-19-009712 · edgar.xml · derivative · entry 4 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,385 shares Expires 2019-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 20:36 UTC | TENNANT CO TNC · Entity 4843 | SaleCommon Stock | 1,660 | $69.07 | $114,652.71 |
DisclosureSEC source: 0001179110-19-009712 · edgar.xml · nonDerivative · entry 3 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,767 F1 · price: Reflects the weighted average price of 1,660 shares of common stock of Tennant Company sold by the reporting person in multiple transactions on August 16, 2019 with sale prices ranging from $69.02 to $69.14 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 20:36 UTC | TENNANT CO TNC · Entity 4843 | Exercise / conversionCommon Stock | 2,256 | $34.28 | $77,335.68 |
DisclosureSEC source: 0001179110-19-009712 · edgar.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 20:36 UTC | TENNANT CO TNC · Entity 4843 | Exercise / conversionCommon Stock | 1,385 | $26.46 | $36,647.10 |
DisclosureSEC source: 0001179110-19-009712 · edgar.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 20:23 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 617 | $244.25 | $150,702.25 |
DisclosureSEC source: 0001209191-19-046318 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904,005.538 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 21:50 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 152.982 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-039334 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904,519.864 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| May 08, 2019 Filed May 10, 2019 22:00 UTC | TENNANT CO TNC · Entity 4843 | GrantCommon Stock | 1,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005895 · edgar.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,786 F1 · shares: Non-Employee Director restricted stock unit grant. Read SEC document |
| May 03, 2019 Filed May 6, 2019 12:32 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | PurchaseCommon Stock | 20,000 | $231.79 | $4,635,730.00 |
DisclosureSEC source: 0001209191-19-027605 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904,366.882 F1 · shares: Shares purchased on the open market. F2 · price: This transaction was executed in multiple trades ranging from $231.675 to $231.84 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:46 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 122.361 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020787 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 884,366.882 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:41 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 68,406 | $0.00 Strike: $262.98 | $0.00 |
DisclosureSEC source: 0001209191-19-014639 · doc4.xml · derivative · entry 5 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,406 Underlying: Common Stock · 68,406 shares Expires 2029-02-26 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.